Pregnancy RSV Vaccine Slashes Newborn Hospital Admissions
TL;DR
A vaccine given during pregnancy to protect newborns from RSV—introduced in 2024 from week 28—has reduced infant RSV hospital admissions by about 80% (nearly 85% if the vaccine is given at least four weeks before birth). A UKHSA study of ~300,000 births in England shows strongest protection when vaccination occurs in the late third trimester, with some benefit even if the baby is born earlier. Uptake is around 64% in England, and doctors urge pregnant people to discuss vaccination with their midwife and aim for vaccination at week 28 or soon after to protect babies through winter.
Topics:health#health#infant-hospitalizations#newborn-protection#pregnancy-vaccine#respiratory-syncytial-virus#uk-health-security-agency
- Pregnancy vaccine reduces baby hospital admissions for RSV by 80% BBC
- Vaccinating pregnant women against RSV significantly reduces infant hospitalisations, says study Yahoo
- The impact of maternal respiratory syncytial virus vaccination on infant and perinatal outcomes: a systematic review and meta-analysis of randomized controlled trials Nature
- FDA advisers support approval of RSV vaccine to protect infants WVIA Public Media
- RSV Vaccination in Late Pregnancy Reduces Infant Hospitalizations Inside Precision Medicine
Want the full story? Read the original reporting
Read on BBC